Paper · 4140983
Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.
Eddleston AL and 1 other. Lancet, 1974. Cited by 336 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Papers, record 4140983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4140983
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Formation | Major topic |
| Hepatitis | Major topic |
| Hepatitis B | Major topic |
| Hepatitis B Antigens | Major topic |
| T-Lymphocytes | Major topic |
| Acute Disease | |
| Animals | |
| Autoantibodies | |
| Autoimmune Diseases | |
| B-Lymphocytes | |
| Cell Membrane | |
| Chronic Disease | |
| Cytotoxicity Tests, Immunologic | |
| Epitopes | |
| HLA Antigens | |
| Hepatitis B Antibodies | |
| Humans | |
| Immunity, Cellular | |
| Immunoglobulins | |
| Immunotherapy | |
| Lipoproteins | |
| Liver | |
| Rabbits |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by99
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 336 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9,952,238 | Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection. | Dig Dis Sci | 1999 | https://conductscience.org/library/papers/9952238 | PubMed |
| 8,089,217 | Increased tumour necrosis factor alpha production by neutrophils in patients with hepatitis B. | J Clin Pathol | 1994 | https://conductscience.org/library/papers/8089217 | PubMed |
| 8,002,792 | Radioimmunoprecipitation and immunoblot studies of antibodies to rubella virus in patients with chronic liver disease. | Arch Virol | 1994 | https://conductscience.org/library/papers/8002792 | PubMed |
| 7,693,538 | Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B. | Gastroenterol Jpn | 1993 | https://conductscience.org/library/papers/7693538 | PubMed |
| 7,648,989 | Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7648989 | PubMed |
| 7,648,988 | Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7648988 | PubMed |
| 7,587,773 | Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7587773 | PubMed |
| 7,429,318 | Antibodies to a human liver membrane lipoprotein (LSP) in primary biliary cirrhosis. | Gut | 1980 | https://conductscience.org/library/papers/7429318 | PubMed |
| 7,387,169 | Autoimmune haemolytic anaemia in an asymptomatic carrier of hepatitis B virus. | Arch Dis Child | 1980 | https://conductscience.org/library/papers/7387169 | PubMed |
| 7,342,406 | Macular and paramacular detachment of the neurosensory retina associated with systemic diseases. | Trans Am Ophthalmol Soc | 1981 | https://conductscience.org/library/papers/7342406 | PubMed |
1 to 10 of 99
See all 99 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4140983
GET https://conductscience.org/api/papers/v1/4140983/cited_by?page=2